Results 161 to 170 of about 20,538 (302)

Geometric Microstructural Characteristics of White Matter Differentiate Patients With Facial Dyskinesias and Palsy. [PDF]

CNS Neurosci Ther
Zhu H, Yang A, Luan J, Xu M, Liu B, Lv K, Hu P, Shmuel A, Zhu H, Yuan Z, Shu N, Cheng J, Ma G.   +12 more
europepmc   +1 more source

Conditional Modeling of GNAO1 Disorder Dissociates Circuit Specific Contributions to Pathology and Rationalizes Ameliorative Strategies

Movement Disorders, EarlyView.
Abstract Background Neurodevelopmental disorders feature various symptoms that frequently include seizures and motor manifestations, but their attribution to disruptions of specific circuits and molecular alterations is notoriously hard to establish, which limits therapeutic interventions.
Gloria Brunori, Stefano Zucca, Colten K. Lankford, Yi‐Zhi Wang, Marianna Franco, Nina A. Alekseeva, Sevinj Ahmedova, Han My Van, Jeffrey N. Savas, Kirill A. Martemyanov   +9 more
wiley   +1 more source

Occurrence of Motor Complications and Gait Problems After Introduction of Medical Treatment in Parkinson's Disease. [PDF]

Parkinsons Dis
Osaki Y, Morita Y, Ohtsuru S, Shogase T, Yoshimoto D, Miyoshi T, Ikeda T, Hashimoto Y, Matsushita T.   +8 more
europepmc   +1 more source

Macroscale Gradient‐Informed Neural Oscillation Topography in Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Parkinson's disease (PD) is characterized by large‐scale disruptions in beta and gamma oscillations. Although subcortical beta power is an established biomarker for current adaptive deep brain stimulation (aDBS), it may not fully capture the global pathophysiological burden and the macroscale hierarchical reorganization of the ...
Hao Ding, Ke Xie, Manuel Bange, Hannah Kühne, Jenny Blech, Bahman Nasseroleslami, Jens Volkmann, Sergiu Groppa, Muthuraman Muthuraman   +8 more
wiley   +1 more source

Foslevodopa-Foscarbidopa subcutaneous infusion in Parkinson's disease: a cross-cultural/cross-racial international multicentre comparative tolerability study (CRIM-FOS study). [PDF]

Sci Rep
Metta V, Poplawska-Domaszewicz K, Brek O, Hussain H, Nalarakettil A, Masagnay T, Sangilan C, Elmahdy M, Odin P, Chaudhuri KR.   +9 more
europepmc   +1 more source

Expanding the Phenotype of PARK‐PRKN to Spastic Paraplegia: A Report of Two Cases

Movement Disorders Clinical Practice, EarlyView.
Nicolas Geoffre, Thomas Ollivier, Guillaume Baille, Luc Defebvre, Vincent Huin, Eugenie Mutez   +5 more
wiley   +1 more source

Adaptive Deep Brain Stimulation for Parkinson's Disease: Navigating the Roadblocks to Clinical Implementation

Movement Disorders, EarlyView.
Abstract Adaptive deep brain stimulation (aDBS) represents an important evolution in the treatment of Parkinson's disease (PD), building on conventional DBS (cDBS) by adjusting stimulation in response to real‐time physiological signals. By enabling dynamic targeting of disease‐related neural activity, aDBS offers the potential for more precise ...
Thomas Koeglsperger, Maximilian Scherer, Andrea A. Kühn, Alexandre Eusebio, Alfonso Fasano, Joachim K. Krauss   +5 more
wiley   +1 more source

Levodopa-Induced Oculogyric Crisis in Multiple System Atrophy. [PDF]

J Mov Disord
Turgunkhujaev O, Bagdasarova E, Lim SY.
europepmc   +1 more source

Faith, fasting, and well-being: Emirates Neurology Society consensus guidelines on safe Ramadan fasting in Parkinson's disease. [PDF]

Front Neurol
Mittal SO, Krystkowiak P, Ramberg CJ, Sarathchandran P, Hassan A, Iantorno V, Cirasanambati M, Al Aloma M, Maiti T, Al Rukn S.   +9 more
europepmc   +1 more source

Severe Lower Limb and Abdominal Edema Associated with Subcutaneous Apomorphine Infusion

Movement Disorders Clinical Practice, EarlyView.
Guillaume Costentin, David Maltête
wiley   +1 more source